Hemtex’s Extraordinary Shareholders’ Meeting approved the rights issue

The Extraordinary Shareholders’ Meeting of Hemtex AB (publ) today approved the Board of Directors’ resolution of April 6, 2009 on a rights issue in Hemtex with preferential rights for existing shareholders. According to the terms of the rights issue, which were set by the Board of Directors on April 17, 2009, each shareholder has a preferential right to subscribe for two new shares for every five existing shares held. The subscription price is SEK 14 per share and the total proceeds from the rights issue will be approximately SEK 164 million.

Where all shares have not been subscribed for by virtue of subscription rights, the Board of Directors shall resolve on the allocation of shares subscribed for without subscription rights. Allocation shall firstly be made to those that subscribed for shares by virtue of subscription rights, regardless of whether or not the subscriber was a shareholder on the record date and, in case of over subscription, in relation to the number of subscription rights used for subscription of shares and, where this is not possible, by drawing of lots. Secondly, allocation shall be made to others that have applied for subscription without subscription rights and, in case they cannot receive full allocation, in relation to the number of shares that each has applied for subscription and, where this is not possible, by drawing of lots. Thirdly, allocation shall be made to the underwriter, Hakon Invest AB.

As a result of the rights issue Hemtex’s share capital will increase by not more than SEK 29,337,400 and the maximum number of new shares is 11,734,960.

The record day at Euroclear Sweden AB for participation in the rights issue is April 24, 2009. The last day of trading in Hemtex shares, including the right to participate in the rights issue, is April 21, 2009. The prospectus is expected to be distributed on or about April 27, 2009. Subscription will take place during the subscription period of April 29 – May 13, 2009 or such later date as resolved by the Board of Directors.

Financial and legal advisers

Swedbank Markets is Hemtex’s financial adviser and Gernandt & Danielsson is the legal adviser.